IRIS UniCatt

De Stefano, Valerio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.399
AS - Asia 7.747
EU - Europa 7.099
SA - Sud America 1.667
AF - Africa 218
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 10
Totale 26.167
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.065
SG - Singapore 3.738
DE - Germania 1.695
CN - Cina 1.565
BR - Brasile 1.346
IT - Italia 1.247
SE - Svezia 1.179
VN - Vietnam 781
FR - Francia 641
UA - Ucraina 490
IE - Irlanda 372
GB - Regno Unito 367
IN - India 275
FI - Finlandia 270
ID - Indonesia 262
PL - Polonia 256
BD - Bangladesh 232
JP - Giappone 183
RU - Federazione Russa 183
CA - Canada 152
HK - Hong Kong 151
AR - Argentina 132
MX - Messico 111
IQ - Iraq 105
TR - Turchia 85
AT - Austria 74
NL - Olanda 62
ZA - Sudafrica 56
PK - Pakistan 52
ES - Italia 49
SA - Arabia Saudita 42
BE - Belgio 41
EC - Ecuador 41
KR - Corea 40
CO - Colombia 34
VE - Venezuela 34
CI - Costa d'Avorio 29
MA - Marocco 25
UZ - Uzbekistan 24
CZ - Repubblica Ceca 23
IR - Iran 23
AU - Australia 22
CL - Cile 22
PY - Paraguay 21
AE - Emirati Arabi Uniti 20
LT - Lituania 20
PH - Filippine 19
DZ - Algeria 18
KE - Kenya 18
AZ - Azerbaigian 16
CH - Svizzera 16
JO - Giordania 16
PE - Perù 16
RO - Romania 16
TN - Tunisia 16
EG - Egitto 14
JM - Giamaica 14
OM - Oman 14
HU - Ungheria 13
NP - Nepal 13
IL - Israele 12
MY - Malesia 12
UY - Uruguay 12
CR - Costa Rica 10
PT - Portogallo 10
TH - Thailandia 10
DO - Repubblica Dominicana 9
KZ - Kazakistan 9
LB - Libano 9
ET - Etiopia 8
GR - Grecia 8
MD - Moldavia 8
NO - Norvegia 8
SN - Senegal 8
AL - Albania 7
BO - Bolivia 7
LV - Lettonia 7
BG - Bulgaria 6
GT - Guatemala 6
HN - Honduras 6
HR - Croazia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AM - Armenia 5
BH - Bahrain 5
DK - Danimarca 5
EE - Estonia 5
LY - Libia 5
NI - Nicaragua 5
PA - Panama 5
TW - Taiwan 5
BY - Bielorussia 4
KG - Kirghizistan 4
NG - Nigeria 4
PR - Porto Rico 4
BB - Barbados 3
BZ - Belize 3
LA - Repubblica Popolare Democratica del Laos 3
MK - Macedonia 3
RS - Serbia 3
SY - Repubblica araba siriana 3
Totale 26.113
Salva come PNG Salva come JPEG
Città #
Singapore 2.003
Chandler 1.169
Ashburn 898
San Jose 866
Dublin 364
Beijing 314
Jacksonville 279
San Mateo 277
Rome 255
Munich 254
Ho Chi Minh City 251
Los Angeles 239
New York 237
Dallas 223
Jakarta 223
Warsaw 212
Wilmington 212
Lauterbourg 206
Hanoi 197
Nanjing 187
Milan 178
Boston 169
Ann Arbor 161
Cattolica 160
Tokyo 150
Fairfield 147
Dearborn 143
Hong Kong 136
Hefei 133
Houston 126
Woodbridge 122
Helsinki 110
Frankfurt am Main 109
Moscow 104
São Paulo 102
Princeton 100
Chicago 96
Marseille 95
Redmond 95
Seattle 93
The Dalles 91
Lawrence 90
Redwood City 75
Nanchang 68
Hyderabad 64
Santa Clara 64
Buffalo 61
Boardman 60
Council Bluffs 56
Orem 52
Da Nang 50
Nuremberg 49
Nürnberg 49
Rio de Janeiro 47
Paris 46
Bremen 43
London 43
Toronto 40
Belo Horizonte 38
Brussels 37
Kent 37
Norwalk 37
Hebei 35
Montreal 35
Seoul 35
Atlanta 34
Baghdad 34
Johannesburg 33
Kunming 33
Mountain View 33
Vienna 33
Guangzhou 32
Haiphong 32
Cambridge 31
Florence 31
Mexico City 31
Brooklyn 30
Hangzhou 30
Shanghai 30
University Park 30
Washington 30
Zhengzhou 30
Abidjan 29
San Francisco 29
Tianjin 29
Shenyang 28
Detroit 27
Düsseldorf 26
Jiaxing 26
Lancaster 26
Memphis 26
Poplar 26
Pune 26
Dhaka 25
Izmir 25
Leawood 25
St Louis 25
Turku 25
Naples 24
Changsha 23
Totale 13.704
Salva come PNG Salva come JPEG
Nome #
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 343
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 329
Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients. 326
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 285
Fondaparinux in pregnancy: Could it be a safe option? A review of the literature. 278
Association of congenital protein C deficiency and latent myeloproliferative disease as cause of splanchnic venous thrombosis in a 34-year-old woman 251
Haemostatic alterations induced by treatment with asparaginases and clinical consequences 243
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 242
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 234
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 225
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 201
A real-time integrated framework to support clinical decision making for covid-19 patients 200
Risk factor and etiology analysis of ischemic stroke in young adult patients 199
Health Technology Assessment of genetic testing for susceptibility to Venous Thromboembolism in Italy 197
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry 196
Allogeneic cord blood transfusions prevent fetal haemoglobin depletion in preterm neonates. Results of the CB-TrIP study 194
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment 191
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 190
Safety of granulocyte-colony-stimulating factor in acute myocardial infarction (the Rigenera study). 183
Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect 183
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 181
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis 179
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment 176
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 175
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 174
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms 174
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 174
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 173
Factor V deficiency in pregnancy complicated by Rh immunization and placenta previa. A case report and review of the literature 171
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 169
Venous thromboembolism in multiple myeloma 168
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B(2) assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 166
Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms 165
A Case of Heparin Allergy With Good Tolerability to Fondaparinux During Pregnancy 165
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 164
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments 161
Bisphosphonate therapy in multiple myeloma in preventing vertebral collapses: preliminary report 160
Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis) 158
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN 157
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 157
Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms 156
Ineherited Thrombophilia: treatment during pregnancy 154
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 153
Postpartum hemorrhage 151
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 151
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 150
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 149
Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers 149
Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease 147
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 147
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 146
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 146
Autoimmune hemolytic anemia with gel-based immunohematology tests: neural network analysis 145
Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluation 145
Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms 144
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 144
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 144
JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis 142
A Case of Heparin Allergy With Good Tolerability to Fondaparinux During Pregnancy. 141
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 141
A STARD-compliant prediction model for diagnosing thrombotic microangiopathies 139
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 138
Prognostic Factors Associated With Progression of Smoldering Multiple Myeloma to Symptomatic Form 138
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 137
Increased prevalence of the G20210A prothrombin gene variant in acute coronary syndromes without metabolic or acquired risk factors or with limited extent of disease 136
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate 135
IgD multiple myeloma a descriptive report of 17 cases: survival and response to therapy 135
The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia 134
Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study 132
Factor V deficiency in pregnancy complicated by Rh immunization and placenta previa. A case report and review of the literature 130
Inherited thrombophilia: treatment during pregnancy. 129
Digital morphology compared to the optical microscope: A validation study on reporting bone marrow aspirates 128
Obstetric complications and pregnancy-related venous thromboembolism: The effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation 128
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment 126
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 126
In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband 123
High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with Vitamin K antagonists 123
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells 122
Early mortality in myeloma patients treated with first-generation novel agents thalidomide, lenalidomide, bortezomib at diagnosis: A pooled analysis 122
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 121
Platelet indices and glucose control in type 1 and type 2 diabetes mellitus: A case-control study 121
Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients 120
Ultrasound-Doppler diagnosis of Budd-Chiari syndrome 119
THE IMPACT OF EDUCATION ON PATIENTS' PSYCHOEMOTIONAL STATUS DURING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE PROSPECTIVE STUDY BY THE GRUPPO ITALIANO TRAPIANTO MIDOLLO OSSEO 118
Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European Leukemia Net study 118
The C807T/G873A polymorphism in the platelet glycoprotein Ia gene and the risk of acute coronary syndrome in the Italian population 118
The Effects of Granulocyte Colony-Stimulating Factor in Patients with a Large Anterior Wall Acute Myocardial Infarction to Prevent Left Ventricular Remodeling: A 10-Year Follow-Up of the RIGENERA Study 118
Improved Detection of Minimal Residual Disease by 11C-Methionine PET/CT in a Young Patient With Unusual Extramedullary Presentation of Recurrent Multiple Myeloma 117
Nutritional status and quality of life in adults undergoing allogeneic hematopoietic stem cell transplantation 117
Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial 115
Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups 115
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 115
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All-Trans Retinoic Acid: A Monocentric Experience 114
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 114
Splanchnic vein thrombosis in myeloproliferative neoplasms: Risk factors for recurrences in a cohort of 181 patients 112
Italian daily platelet transfusion practice for haematological patients undergoing high dose chemotherapy with or without stem cell transplantation: A survey by the GIMEMA Haemostasis and Thrombosis Working Party 111
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 111
Primary plasma cell leukemia: a retrospective multicenter study of 73 patients 110
Cerebral sinus-venous thrombosis 110
Pre-Exposure to Defibrotide Prevents Endothelial Cell Activation by Lipopolysaccharide: An Ingenuity Pathway Analysis 110
Totale 15.907
Salva come PNG Salva come JPEG
Categoria #
all - tutte 115.867
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.867
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202126 0 0 0 0 0 0 0 0 0 0 0 26
2021/20221.674 130 103 25 76 100 29 24 259 81 108 320 419
2022/20233.370 509 476 294 484 206 378 178 226 368 91 110 50
2023/20241.742 74 506 57 78 77 234 107 96 32 60 188 233
2024/20254.006 98 135 275 122 337 114 217 215 638 392 766 697
2025/202610.538 1.528 320 761 1.125 1.830 523 1.697 491 688 675 479 421
Totale 26.536